Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 989 of 5804
-
New drug hope for GPA patients with stubborn ENT symptoms
Disease control Not yet recruitingThis is a single center double-blind placebo-controlled study. Patients with GPA and active ears, nose, and throat (ENT) disease in at least two ENT domains, as defined after endoscopic visualization of the upper airway and audiometric evaluation, if applicable, by a single otola…
Phase: PHASE2, PHASE3 • Sponsor: Robert Spiera, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a phone app help young people with diabetes control blood sugar?
Disease control Not yet recruitingThis is a clinical trial that includes a run-in period, a 90 day micro-randomized trial, and a 90-day observational period. The goal of this study is to evaluate whether providing paired real time glycemic and health behavior data in a smartphone app leads to better glycemic cont…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Ketamine pills could ease debilitating CRPS pain – new trial underway
Symptom relief Not yet recruitingThe purpose of this study is to evaluate the efficacy of Ketamine HCl Prolonged Release (PR) tablets in participants with pain due to complex regional pain syndrome (CRPS). Additionally, this trial will explore the feasibility of the trial design through dosing compliance, clini…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Could a Placenta-Based bandage heal stubborn leg wounds?
Disease control Not yet recruitingThis is a randomized controlled trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating venous leg ulcers.
Phase: NA • Sponsor: NuScience Medical Biologics, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a simple blood test spot hidden cancers? new study aims to find out
Diagnosis Not yet recruitingThe purpose of this research study is to evaluate the possible benefits of screening with an investigational, but commercially available blood test designed to detect many types of cancer. The name of the screening blood test being studied is: -GRAIL Galleri MCED test
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
New hope for AML patients who fail venetoclax?
Disease control Recruiting nowThis is a prospective, single-arm phase 2 pilot study to assess the response rate of IDH1 mutated relapsed/refractory acute myeloid leukemia (AML) patients who receive olutasidenib after progressing on venetoclax based regimens. Each cycle will last for 28 days. Patients will rec…
Phase: PHASE2 • Sponsor: Timothy Pardee • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug aims to starve prostate cancer by blocking testosterone
Disease control Not yet recruitingThe purpose of this clinical trial is to test the effectiveness of a dosing regimen of Teverelix DP castration rate defined as the cumulative probability of testosterone suppression to \< 0.5 ng/mL with the lower bound of the 95% confidence interval (CI) being \> 90% to meet the …
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Personalized dosing may boost lupus kidney remission
Disease control Not yet recruitingSystemic lupus erythematosus (SLE) is an inflammatory, chronic, and multisystem autoimmune disease characterized by periods of activity and remission. Lupus nephritis (LN) is the most frequent renal complication and is associated with high morbidity, manifesting as nephritic or n…
Phase: NA • Sponsor: Federal University of Maranhao • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a Gut-Healing shot fix hidden malnutrition?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether teduglutide, a medicine that helps the intestine heal, can improve environmental enteric dysfunction in undernourished women aged 18 to 35 years living in urban slums of Dhaka. Environmental enteric dysfunction is a long-lastin…
Phase: PHASE2 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug hopes to strengthen muscles in rare genetic disorder
Disease control Recruiting nowThis study is testing a medicine called surlorian in adults who have a genetic muscle condition known as autosomal dominant RYR1-related myopathy (RYR1-RM). The goal is to find out whether surlorian improves muscle weakness, and whether it is safe and well tolerated.
Phase: PHASE2 • Sponsor: RyCarma Therapeutics, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can methamphetamine help uncover hidden HIV? a new study investigates
Knowledge-focused Not yet recruitingThe most commonly used illicit stimulant in people with HIV (PWH) is methamphetamine (MA). Prior studies demonstrate strong evidence that MA promotes increased HIV transcription as well as immune dysregulation. A challenge in achieving worldwide HIV eradication is targeting speci…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can we predict sudden cardiac death after a heart attack? new study aims to find out
Knowledge-focused Not yet recruitingAlthough advances in treatment and patient management have considerably improved post-infarction prognosis, the risk of sudden cardiac death remains a major concern. Sudden cardiac death (SCD) is defined as an unexpected death occurring within one hour of the onset of symptoms, o…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New vaccine combo takes on tough lung cancer in early trial
Disease control Not yet recruitingThe purpose of this clinical trial is to evaluate the safety, tolerability, preliminary efficacy, and immunogenicity of EVM14 administered intramuscularly (IM) combination with Ivonescimab in patients with sq-NSCLC.
Phase: PHASE1 • Sponsor: Everest Medicines (Beijing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Ancient herb meets keto: new trial targets fatty liver
Disease control Not yet recruitingThis study employed a single-center, randomized, investigator-blind, three-group parallel, stepwise controlled clinical trial. A total of 135 subjects were randomly assigned to receive either a low-carbohydrate diet intervention, a restrictive ketogenic diet intervention, or a de…
Phase: PHASE2 • Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New study aims to unlock secrets of penetrating brain injuries
Knowledge-focused Not yet recruitingThe purpose of this research study is to prospectively collect biospecimens, imaging, and clinical data from patients with penetrating brain injuries across high-volume PBI sites in the US (including UChicago). Biospecimens will undergo biomarker analysis - biomarker data specifi…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Could remote hand exercises ease Parkinson's symptoms?
Disease control Recruiting nowThe aim of this study is to compare the effects of tele-rehabilitation-based synchronous and asynchronous dual-task upper extremity training with clinical based dual-task upper extremity training and conventional single-task upper extremity training in patients with Parkinson's d…
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Scientists track hidden threat of antibiotic resistance in lung patients
Knowledge-focused Not yet recruitingAntimicrobial resistance (AMR) refers to the ability of microorganisms like bacteria, viruses, fungi and parasites to resist the effects of antimicrobial drugs (such as antibiotics) which are widely used as treatment. AMR poses an escalating global health threat, contributing to …
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Extended look at gotistobart: could Long-Term use improve survival in advanced cancers?
Disease control Not yet recruitingThis LTE study will examine the long-term overall survival and safety of gotistobart in patients with advanced solid tumors.
Phase: PHASE3 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New ultrasound technique could eliminate need for contrast dye in pancreatic cyst exams
Diagnosis Not yet recruitingThere are many types of pancreatic cysts, and papillary intraductal mucinous pancreatic tumours (PIMPTs) are among the most common. PIMPTs carry a risk of progressing to a cancerous lesion. To assess this risk, the key examination involves performing an endoscopic ultrasound com…
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Could ChatGPT-Style AI help triage emergency patients? a massive study puts it to the test
Knowledge-focused OngoingThis retrospective, non-interventional study evaluates the prognostic performance of open-weight Large Language Models (LLMs) in the setting of a German academic emergency department. Using a full census of all consecutive emergency department cases at University Hospital Cologne…
Sponsor: University of Cologne • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC